Organization · Venture Capital
GrayBella Capital
GrayBella Capital is a pan-European venture capital firm based in London, focusing on growth-stage investments in HealthTech and DeepTech sectors. The firm targets innovative companies with disruptive potential across various technology domains.
Overview
What GrayBella Capital does
What GrayBella Capital is
GrayBella Capital is a pan-European venture capital firm based in London, focusing on growth-stage investments in HealthTech and DeepTech sectors. The firm targets innovative companies with disruptive potential across various technology domains.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find GrayBella Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
GrayBella Capital as a funder
Investment thesis
GrayBella Capital invests in growth-stage technology-driven companies in HealthTech and DeepTech, aiming to support innovative projects that can disrupt industries.
Focus narrative
GrayBella Capital primarily invests in HealthTech and DeepTech sectors. In HealthTech, they focus on areas such as Diagnostics, Healthcare IT, Patient Monitoring, and Embedded Software. In DeepTech, they cover technologies like IoT, Cloud Computing, SaaS Platforms, AI, Machine Learning, Data Science, Quantum Computing, and Nanotechnologies. The firm typically provides growth capital investments ranging from €3 million to €15 million.
Value beyond capital
GrayBella Capital adds value to its portfolio companies by leveraging its expertise in HealthTech and DeepTech, providing strategic guidance, and facilitating connections within the industry to enhance growth and innovation.
Terms and economics
- Typical check
- $3,000,000–$15,000,000
Focus and fit
- Stages
- Series A · Series B · Series C
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include Omnio Global, a banking-as-a-service platform; ATAI Life Science, which focuses on transforming mental health treatment using psychedelics; CN-Bio, a leader in organ-on-chip technology for drug discovery; and BC Platforms, a global leader in data networks for personalized medicine.
Common questions
What to know about GrayBella Capital
Upseed classifies GrayBella Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.